Macy’s Reported Great Earnings and Sonoma Pharmaceuticals Released Dental Products
Macy’s is a retail giant located in the heart of New York City. It has hundreds of department stores worldwide, and they sell things like apparel, accessories, and other consumer goods. You’ve likely seen a Macy’s if you’ve gone to the mall, although most of us do our shopping online now. Macy’s has a market cap of $6.739 billion, and they have massively rebounded from their 52-week low of $5.57.
On Thursday, Macy’s reported stellar second quarter earnings. The company saw earnings of $1.29 per share, which beat expectations, and they reported revenue numbers of $5.65 billion, which crushed expectations. Macy’s also reinstated their 15-cent quarterly dividend while also authorizing a $500 million stock buyback, which capped off the awesome earnings report. Macy’s closed the day at $21.61, up 19.59%.
Sonoma Pharmaceuticals is a healthcare company located in the northern part of Atlanta, Georgia. They have a market cap of $17.053 million, which means they are a nano-cap company. You can tell this one’s gonna be volatile!
On Thursday, Sonoma released two new dental products in the United States and Switzerland, the OroGenix Oral Hygiene Rinse and Microdacyn Oral Care, which both aim to help with oral health. Sonoma had only 1 product in the market before yesterday, so this would provide a major revenue boost for the small company. Investors liked this as Sonoma closed at $8.15 cents, up 50.65%.
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.